21 – 30 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good Prognosis Diffuse Large B Cell Lymphoma (DLBCL) Results of the 6 Year Follow up of the Mint Study of the Mabthera International Trial (Mint) Group
(
- Contribution to journal › Published meeting abstract
-
Mark
CNS Disease In Younger Patients (
(
- Contribution to journal › Published meeting abstract
-
Mark
Intensive Induction Chemotherapy Followed by Autologous Stem Cell Transplantation (ASCT) In Patients with Enteropathy Associated T Cell Lymphoma a Prospective Study by the Nordic Lymphoma Group (NLG T 01)
(
- Contribution to journal › Published meeting abstract
-
Mark
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study
(
- Contribution to journal › Article
-
Mark
Sperm DNA Integrity in Men Treated for Childhood Cancer.
(
- Contribution to journal › Article
-
Mark
Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.
(
- Contribution to journal › Article
- 2009
-
Mark
Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA
2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Hypogonadism Risk in Men Treated for Childhood Cancer.
(
- Contribution to journal › Article
-
Mark
Sperm DNA integrity in cancer patients : the effect of disease and treatment
(
- Contribution to journal › Article
-
Mark
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program.
(
- Contribution to journal › Article